# Spectrum Brands Holdings, Inc.: financial statements, quarterly

SPB · NYSE · CIK 109177 · [Technology](/sectors/technology.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/spb.md) · [Financials](/companies/spb/financials.md) · [Filings](/companies/spb/filings.md) · [Insiders](/companies/spb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/spb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [741 d](/filings/0000109177-25-000043.md) | [692](/filings/0000109177-25-000009.md) | [719](/filings/0000109177-25-000015.md) | [779](/filings/0001628280-25-038659.md) | [774 d](/filings/0000109177-25-000043.md) | [700](/filings/0000109177-26-000010.md) | [676](/filings/0000109177-26-000021.md) | [700](/filings/0000109177-26-000040.md) | [734 d](/filings/0000109177-25-000043.md) | [677](/filings/0000109177-26-000010.md) | [709](/filings/0000109177-26-000021.md) | [753](/filings/0000109177-26-000040.md) |
| Cost of revenue | $m | [496 d](/filings/0000109177-25-000043.md) | [447](/filings/0000109177-25-000009.md) | [445](/filings/0000109177-25-000015.md) | [477](/filings/0001628280-25-038659.md) | [486 d](/filings/0000109177-25-000043.md) | [442](/filings/0000109177-26-000010.md) | [422](/filings/0000109177-26-000021.md) | [436](/filings/0000109177-26-000040.md) | [477 d](/filings/0000109177-25-000043.md) | [435](/filings/0000109177-26-000010.md) | [439](/filings/0000109177-26-000021.md) | [383](/filings/0000109177-26-000040.md) |
| Gross profit | $m | [244 d](/filings/0000109177-25-000043.md) | [245](/filings/0000109177-25-000009.md) | [273](/filings/0000109177-25-000015.md) | [303](/filings/0001628280-25-038659.md) | [288 d](/filings/0000109177-25-000043.md) | [258](/filings/0000109177-26-000010.md) | [253](/filings/0000109177-26-000021.md) | [264](/filings/0000109177-26-000040.md) | [257 d](/filings/0000109177-25-000043.md) | [242](/filings/0000109177-26-000010.md) | [270](/filings/0000109177-26-000021.md) | [370](/filings/0000109177-26-000040.md) |
| Research and development | $m | [5.9 d](/filings/0000109177-25-000043.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [217 d](/filings/0000109177-25-000043.md) | [220](/filings/0000109177-25-000009.md) | [224](/filings/0000109177-25-000015.md) | [250](/filings/0001628280-25-038659.md) | [264 d](/filings/0000109177-25-000043.md) | [213](/filings/0000109177-26-000010.md) | [218](/filings/0000109177-26-000021.md) | [225](/filings/0000109177-26-000040.md) | [226 d](/filings/0000109177-25-000043.md) | [215](/filings/0000109177-26-000010.md) | [227](/filings/0000109177-26-000021.md) | [251](/filings/0000109177-26-000040.md) |
| Operating income | $m | [16.2 d](/filings/0000109177-25-000043.md) | [25.0](/filings/0000109177-25-000009.md) | [75.9](/filings/0000109177-25-000015.md) | [47.7](/filings/0001628280-25-038659.md) | [22.0 d](/filings/0000109177-25-000043.md) | [44.7](/filings/0000109177-26-000010.md) | [19.5](/filings/0000109177-26-000021.md) | [31.3](/filings/0000109177-26-000040.md) | [29.4 d](/filings/0000109177-25-000043.md) | [27.1](/filings/0000109177-26-000010.md) | [43.5](/filings/0000109177-26-000021.md) | [15.9](/filings/0000109177-26-000040.md) |
| Interest expense | $m | [12.2 d](/filings/0000109177-25-000043.md) | [19.2](/filings/0000109177-24-000013.md) | [16.9](/filings/0000109177-24-000022.md) | [15.7](/filings/0001628280-25-038659.md) | [6.7 d](/filings/0000109177-25-000043.md) | [6.2](/filings/0000109177-26-000010.md) | [7.5](/filings/0000109177-26-000021.md) | [8.4](/filings/0000109177-26-000040.md) | [7.9 d](/filings/0000109177-25-000043.md) | [6.8](/filings/0000109177-26-000010.md) | [7.3](/filings/0000109177-26-000021.md) | [8.2](/filings/0000109177-26-000040.md) |
| Income tax | $m | [(23.5) d](/filings/0000109177-25-000043.md) | [12.4](/filings/0000109177-25-000009.md) | [25.5](/filings/0000109177-25-000015.md) | [22.4](/filings/0001628280-25-038659.md) | [4.0 d](/filings/0000109177-25-000043.md) | [11.8](/filings/0000109177-26-000010.md) | [9.6](/filings/0000109177-26-000021.md) | [1.5](/filings/0000109177-26-000040.md) | [(35.9) d](/filings/0000109177-25-000043.md) | [(8.9)](/filings/0000109177-26-000010.md) | [14.3](/filings/0000109177-26-000021.md) | [28.8](/filings/0000109177-26-000040.md) |
| Net income | $m | [16.8 d](/filings/0000109177-25-000043.md) | [29.1](/filings/0000109177-25-000009.md) | [61.1](/filings/0000109177-25-000015.md) | [6.1](/filings/0001628280-25-038659.md) | [28.6 d](/filings/0000109177-25-000043.md) | [23.5](/filings/0000109177-26-000010.md) | [0.9](/filings/0000109177-26-000021.md) | [19.9](/filings/0000109177-26-000040.md) | [55.6 d](/filings/0000109177-25-000043.md) | [28.4](/filings/0000109177-26-000010.md) | [22.1](/filings/0000109177-26-000021.md) | [(26.8)](/filings/0000109177-26-000040.md) |
| Diluted EPS | $ per share | not reported | [0.85](/filings/0000109177-25-000009.md) | [2.01](/filings/0000109177-25-000015.md) | [0.21](/filings/0001628280-25-038659.md) | not reported | [0.84](/filings/0000109177-26-000010.md) | [0.03](/filings/0000109177-26-000021.md) | [0.80](/filings/0000109177-26-000040.md) | not reported | [1.21](/filings/0000109177-26-000010.md) | [0.94](/filings/0000109177-26-000021.md) | [(1.16)](/filings/0000109177-26-000040.md) |
| Basic EPS | $ per share | not reported | [0.85](/filings/0000109177-25-000009.md) | [2.03](/filings/0000109177-25-000015.md) | [0.21](/filings/0001628280-25-038659.md) | not reported | [0.84](/filings/0000109177-26-000010.md) | [0.03](/filings/0000109177-26-000021.md) | [0.80](/filings/0000109177-26-000040.md) | not reported | [1.21](/filings/0000109177-26-000010.md) | [0.95](/filings/0000109177-26-000021.md) | [(1.16)](/filings/0000109177-26-000040.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [754](/filings/0000109177-24-000047.md) | [445](/filings/0000109177-24-000013.md) | [746](/filings/0000109177-24-000022.md) | [158](/filings/0000109177-24-000039.md) | [369](/filings/0000109177-25-000043.md) | [180](/filings/0000109177-25-000009.md) | [96.0](/filings/0000109177-25-000015.md) | [122](/filings/0001628280-25-038659.md) | [124](/filings/0000109177-26-000040.md) | [127](/filings/0000109177-26-000010.md) | [125](/filings/0000109177-26-000021.md) | [259](/filings/0000109177-26-000040.md) |
| Current assets | $m | [2,926](/filings/0000109177-24-000047.md) | [2,516](/filings/0000109177-24-000013.md) | [2,461](/filings/0000109177-24-000022.md) | [1,493](/filings/0000109177-24-000039.md) | [1,579](/filings/0000109177-25-000043.md) | [1,407](/filings/0000109177-25-000009.md) | [1,343](/filings/0000109177-25-000015.md) | [1,339](/filings/0001628280-25-038659.md) | [1,184](/filings/0000109177-26-000040.md) | [1,201](/filings/0000109177-26-000010.md) | [1,272](/filings/0000109177-26-000021.md) | [1,500](/filings/0000109177-26-000040.md) |
| Total assets | $m | [5,258](/filings/0000109177-24-000047.md) | [4,846](/filings/0000109177-24-000013.md) | [4,757](/filings/0000109177-24-000022.md) | [3,755](/filings/0000109177-24-000039.md) | [3,842](/filings/0000109177-25-000043.md) | [3,615](/filings/0000109177-25-000009.md) | [3,537](/filings/0000109177-25-000015.md) | [3,542](/filings/0001628280-25-038659.md) | [3,380](/filings/0000109177-26-000040.md) | [3,423](/filings/0000109177-26-000010.md) | [3,474](/filings/0000109177-26-000021.md) | [3,578](/filings/0000109177-26-000040.md) |
| Current liabilities | $m | [765](/filings/0000109177-24-000047.md) | [749](/filings/0000109177-24-000013.md) | [659](/filings/0000109177-24-000022.md) | [654](/filings/0000109177-24-000039.md) | [687](/filings/0000109177-25-000043.md) | [587](/filings/0000109177-25-000009.md) | [573](/filings/0000109177-25-000015.md) | [553](/filings/0001628280-25-038659.md) | [523](/filings/0000109177-26-000040.md) | [542](/filings/0000109177-26-000010.md) | [554](/filings/0000109177-26-000021.md) | [622](/filings/0000109177-26-000040.md) |
| Total liabilities | $m | [2,740](/filings/0000109177-24-000047.md) | [2,545](/filings/0000109177-24-000013.md) | [2,499](/filings/0000109177-24-000022.md) | [1,670](/filings/0000109177-24-000039.md) | [1,701](/filings/0000109177-25-000043.md) | [1,586](/filings/0000109177-25-000009.md) | [1,652](/filings/0000109177-25-000015.md) | [1,649](/filings/0001628280-25-038659.md) | [1,470](/filings/0000109177-26-000040.md) | [1,524](/filings/0000109177-26-000010.md) | [1,573](/filings/0000109177-26-000021.md) | [1,667](/filings/0000109177-26-000040.md) |
| Long-term debt | $m | [1,547](/filings/0000109177-24-000047.md) | [1,388](/filings/0000109177-24-000013.md) | [1,374](/filings/0000109177-24-000022.md) | [551](/filings/0000109177-24-000039.md) | [551](/filings/0000109177-25-000043.md) | [550](/filings/0000109177-25-000009.md) | [632](/filings/0000109177-25-000015.md) | [656](/filings/0001628280-25-038659.md) | [556](/filings/0000109177-26-000040.md) | [554](/filings/0000109177-26-000010.md) | [576](/filings/0000109177-26-000021.md) | [604](/filings/0000109177-26-000040.md) |
| Current portion of debt | $m | [8.6](/filings/0000109177-24-000047.md) | [8.8](/filings/0000109177-24-000013.md) | [9.0](/filings/0000109177-24-000022.md) | [9.1](/filings/0000109177-24-000039.md) | [9.4](/filings/0000109177-25-000043.md) | [9.2](/filings/0000109177-25-000009.md) | [9.5](/filings/0000109177-25-000015.md) | [10.7](/filings/0001628280-25-038659.md) | [11.7](/filings/0000109177-26-000040.md) | [11.9](/filings/0000109177-26-000010.md) | [12.0](/filings/0000109177-26-000021.md) | [12.2](/filings/0000109177-26-000040.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,518](/filings/0000109177-24-000047.md) | [2,301](/filings/0000109177-24-000013.md) | [2,257](/filings/0000109177-24-000022.md) | [2,085](/filings/0000109177-24-000039.md) | [2,141](/filings/0000109177-25-000043.md) | [2,029](/filings/0000109177-25-000009.md) | [1,885](/filings/0000109177-25-000015.md) | [1,894](/filings/0001628280-25-038659.md) | [1,910](/filings/0000109177-26-000040.md) | [1,899](/filings/0000109177-26-000010.md) | [1,901](/filings/0000109177-26-000021.md) | [1,849](/filings/0000109177-26-000040.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(514) d](/filings/0000109177-25-000043.md) | [(4.3)](/filings/0000109177-25-000009.md) | [3.5 d](/filings/0000109177-25-000015.md) | [82.7 d](/filings/0001628280-25-038659.md) | [80.7 d](/filings/0000109177-25-000043.md) | [(72.4)](/filings/0000109177-26-000010.md) | [23.1 d](/filings/0000109177-26-000021.md) | [81.8 d](/filings/0000109177-26-000040.md) | [171 d](/filings/0000109177-25-000043.md) | [67.4](/filings/0000109177-26-000010.md) | [10.2 d](/filings/0000109177-26-000021.md) | [83.3 d](/filings/0000109177-26-000040.md) |
| Capital expenditure | $m | [14.7 d](/filings/0000109177-25-000043.md) | [8.4](/filings/0000109177-25-000009.md) | [12.5 d](/filings/0000109177-25-000015.md) | [10.1 d](/filings/0001628280-25-038659.md) | [13.0 d](/filings/0000109177-25-000043.md) | [5.9](/filings/0000109177-26-000010.md) | [9.2 d](/filings/0000109177-26-000021.md) | [10.0 d](/filings/0000109177-26-000040.md) | [13.2 d](/filings/0000109177-25-000043.md) | [8.1](/filings/0000109177-26-000010.md) | [9.3 d](/filings/0000109177-26-000021.md) | [9.8 d](/filings/0000109177-26-000040.md) |
| Dividends paid | $m | [14.9 d](/filings/0000109177-25-000043.md) | [14.1](/filings/0000109177-25-000009.md) | [12.7 d](/filings/0000109177-25-000015.md) | [12.0 d](/filings/0001628280-25-038659.md) | [11.8 d](/filings/0000109177-25-000043.md) | [13.2](/filings/0000109177-26-000010.md) | [12.1 d](/filings/0000109177-26-000021.md) | [11.6 d](/filings/0000109177-26-000040.md) | [11.3 d](/filings/0000109177-25-000043.md) | [10.9](/filings/0000109177-26-000010.md) | [10.9 d](/filings/0000109177-26-000021.md) | [10.8 d](/filings/0000109177-26-000040.md) |
| Share repurchases | $m | [34.7 d](/filings/0000109177-25-000043.md) | [243](/filings/0000109177-25-000009.md) | [97.5 d](/filings/0000109177-25-000015.md) | [142 d](/filings/0001628280-25-038659.md) | [0.0 d](/filings/0000109177-25-000043.md) | [72.9](/filings/0000109177-26-000010.md) | [160 d](/filings/0000109177-26-000021.md) | [54.4 d](/filings/0000109177-26-000040.md) | [39.2 d](/filings/0000109177-25-000043.md) | [35.5](/filings/0000109177-26-000010.md) | [6.8 d](/filings/0000109177-26-000021.md) | [15.9 d](/filings/0000109177-26-000040.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-01-01) | Q2 FY2023 (2023-04-02) | Q3 FY2023 (2023-07-02) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-29) | Q2 FY2025 (2025-03-30) | Q3 FY2025 (2025-06-29) | Q1 FY2026 (2025-12-28) | Q2 FY2026 (2026-03-29) | Q3 FY2026 (2026-06-28) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [40.9](/filings/0000109177-24-000013.md) | [41.0](/filings/0000109177-24-000022.md) | [40.4](/filings/0000109177-24-000039.md) | [34.1](/filings/0000109177-25-000009.md) | [30.4](/filings/0000109177-25-000015.md) | [29.1](/filings/0001628280-25-038659.md) | [28.1](/filings/0000109177-26-000010.md) | [26.2](/filings/0000109177-26-000021.md) | [25.0](/filings/0000109177-26-000040.md) | [23.5](/filings/0000109177-26-000010.md) | [23.3](/filings/0000109177-26-000021.md) | [23.1](/filings/0000109177-26-000040.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 22,995,596 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0000109177-26-000040.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.